At present, there is increasing evidence that TNFα inhibition does not correlate with an augmented incidence of cancer [319,320,321], but there are a few reports that show the opposite [322], including two reports that indicate an elevated risk of hematological malignancies and nonmelanoma skin cancers in patients with RA [298,323]. The gene discussed is TNF; the disease is hematologic disorder.